Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function.
暂无分享,去创建一个
James D. Thomas | R. Starling | A. Klein | James B. Young | A. Richards | A. Morehead | T. Yandle | R. Troughton | Maureen G Martin | D. Prior | Allan L. Klein | A. Richards | A. Fogarty | J. Pereira | James D Thomas
[1] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[2] L. Fisher,et al. Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) , 2003, Circulation.
[3] C. Zanker,et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. , 2002, Journal of the American College of Cardiology.
[4] M. Enriquez-Sarano,et al. Quantitation of mitral regurgitation: rationale, approach, and interpretation in clinical practice , 2002, Heart.
[5] G. Habib,et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. , 2002, Circulation.
[6] Douglas W Mahoney,et al. Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.
[7] Alan S Maisel,et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.
[8] M. Redfield,et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. , 2002, Journal of cardiac failure.
[9] A. DeMaria,et al. Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings , 2002, Circulation.
[10] E. Antman,et al. ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .
[11] M. Vogeser,et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. , 2001, Journal of the American College of Cardiology.
[12] K. Swedberg,et al. Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.
[13] L. Lenert,et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. , 2001, Journal of the American College of Cardiology.
[14] L. Tavazzi,et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. , 2001, Journal of the American College of Cardiology.
[15] V. Cameron,et al. Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. , 2000, Endocrinology.
[16] M. Kinoshita,et al. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.
[17] C. Frampton,et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations , 2000, The Lancet.
[18] W. Klein,et al. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy. , 1999, European heart journal.
[19] M. Simoons,et al. Relation of atrial natriuretic peptides to left ventricular systolic and diastolic function in heart failure , 1999, European journal of heart failure.
[20] F. Amiri,et al. Regulation of natriuretic peptide secretion by the heart. , 1999, Annual review of physiology.
[21] W. Shimizu,et al. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia. , 1998, Circulation.
[22] Mario J. Garcia,et al. New Doppler echocardiographic applications for the study of diastolic function. , 1998, Journal of the American College of Cardiology.
[23] C. Frampton,et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. , 1998, Circulation.
[24] H. Tunstall-Pedoe,et al. Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.
[25] G. Lamas,et al. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. , 1997, Circulation.
[26] L. Tavazzi,et al. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. , 1997, Circulation.
[27] Mario J. Garcia,et al. An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. , 1997, Journal of the American College of Cardiology.
[28] J. Gorcsan,et al. Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome. , 1996, Circulation.
[29] J. Sanderson,et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. , 1996, European heart journal.
[30] A. Richards,et al. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. , 1993, The Journal of clinical endocrinology and metabolism.
[31] N Reichek,et al. Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.